137 related articles for article (PubMed ID: 94625)
1. Antiarrhythmic and hemodynamic actions of flecainide acetate (R-818) in the ischemic porcine heart.
Verdouw PD; Deckers JW; Conrad GJ
J Cardiovasc Pharmacol; 1979; 1(4):473-86. PubMed ID: 94625
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease.
Legrand V; Vandormael M; Collignon P; Kulbertus HE
Am J Cardiol; 1983 Feb; 51(3):422-6. PubMed ID: 6823856
[TBL] [Abstract][Full Text] [Related]
3. Comparative hemodynamic effects of Org 7797, flecainide, and propafenone in anesthetized pigs with developing myocardial infarcts.
Winslow E; Mason R
J Cardiovasc Pharmacol; 1992 Mar; 19(3):435-41. PubMed ID: 1378126
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic and antiarrhythmic effects of intravenous flecainide acetate in chronic congestive heart failure.
Dunselman PH; Kingma JH; van Wijk LM; Dijk A; Wesseling H; Lie KI
Drugs; 1985; 29 Suppl 4():58-64. PubMed ID: 4006780
[TBL] [Abstract][Full Text] [Related]
5. [Modification of hemodynamics by intravenous administration of flecainide].
Hoffmeister HM; Hepp A; Seipel L
Z Kardiol; 1986 Mar; 75(3):176-81. PubMed ID: 3705689
[TBL] [Abstract][Full Text] [Related]
6. Effect of flecainide acetate on reperfusion- and barium-induced ventricular tachyarrhythmias in the isolated perfused rat heart.
Ferrara N; Abete P; Leosco D; Caccese P; Orlando M; Landino P; Sederino S; Tedeschi C; Rengo F
Arch Int Pharmacodyn Ther; 1990; 308():104-14. PubMed ID: 2129150
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic, metabolic and hemodynamic effects of Org 6001 (3alpha-amino-5alpha-androstan-2beta-ol-17-one-hydrochloride) after coronary flow reduction in pigs.
Verdouw PD; Schamhardt HC; Remme WJ; De Jong JW
J Pharmacol Exp Ther; 1978 Mar; 204(3):634-44. PubMed ID: 633069
[TBL] [Abstract][Full Text] [Related]
8. Effects of flecainide on atrial and ventricular stimulation thresholds to repetitive extrasystoles and fibrillation and on "2nd Phase" ventricular arrhythmias in dogs.
Heuer H; Gülker H; Thale J; Bender F
Arzneimittelforschung; 1983; 33(12):1651-4. PubMed ID: 6199033
[TBL] [Abstract][Full Text] [Related]
9. Effects of flecainide on occlusion and reperfusion arrhythmias in dogs.
Lederman SN; Wenger TL; Bolster DE; Strauss HC
J Cardiovasc Pharmacol; 1989 Apr; 13(4):541-6. PubMed ID: 2470990
[TBL] [Abstract][Full Text] [Related]
10. Malignant arrhythmias and acute myocardial ischemia: interaction between flecainide and the autonomic nervous system.
Stramba-Badiale M; Lazzarotti M; Facchini M; Schwartz PJ
Am Heart J; 1994 Nov; 128(5):973-82. PubMed ID: 7524295
[TBL] [Abstract][Full Text] [Related]
11. Relationship between plasma concentrations and suppression of ventricular extrasystoles by flecainide acetate (R-818), a new antiarrhythmic, in patients.
Conard GJ; Cronheim GE; Klempt HW
Arzneimittelforschung; 1982; 32(2):155-9. PubMed ID: 7199921
[TBL] [Abstract][Full Text] [Related]
12. Flecainide-induced QRS complex widening correlates with negative inotropy.
Rabêlo Evangelista AB; Monteiro FR; Nearing BD; Belardinelli L; Verrier RL
Heart Rhythm; 2021 Aug; 18(8):1416-1422. PubMed ID: 33848647
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological and haemodynamic effects of vernakalant and flecainide in dyssynchronous canine hearts.
van Middendorp LB; Strik M; Houthuizen P; Kuiper M; Maessen JG; Auricchio A; Prinzen FW
Europace; 2014 Aug; 16(8):1249-56. PubMed ID: 24481779
[TBL] [Abstract][Full Text] [Related]
14. The haemodynamic effect of intravenous flecainide acetate in patients with coronary artery disease.
Serruys PW; Vanhaleweyk G; Van Den Brand M; Verdouw P; Lubsen J; Hugenholtz PG
Br J Clin Pharmacol; 1983 Jul; 16(1):51-9. PubMed ID: 6882622
[TBL] [Abstract][Full Text] [Related]
15. Flecainide: a new antiarrhythmic drug.
Mueller RA; Baur HR
Clin Cardiol; 1986 Jan; 9(1):1-5. PubMed ID: 3510788
[TBL] [Abstract][Full Text] [Related]
16. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
[TBL] [Abstract][Full Text] [Related]
17. Antifibrillatory effects of BRL-32872 in anesthetized Yucatan minipigs with regional myocardial ischemia.
Gout B; Nichols AJ; Feuerstein GZ; Bril A
J Cardiovasc Pharmacol; 1995 Oct; 26(4):636-44. PubMed ID: 8569227
[TBL] [Abstract][Full Text] [Related]
18. [Antiarrhythmic therapy with flecainide in acute experimental myocardial infarction (author's transl)].
Gülker H; Bender F; Brisse B; Thale J; Heuer H; Kristek J; Schindelhauer F; Teerling K
Z Kardiol; 1981 Feb; 70(2):124-30. PubMed ID: 7222906
[TBL] [Abstract][Full Text] [Related]
19. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
Bui-Xuan B; Aupetit JF; Freysz M; Faucon G; Timour Q
Pharmacotherapy; 1997; 17(4):737-45. PubMed ID: 9250551
[TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic effects of flecainide against canine ventricular arrhythmias induced by two-stage coronary ligation and halothane-epinephrine.
Dobmeyer D; Muir WW; Schaal SF
J Cardiovasc Pharmacol; 1985; 7(2):238-44. PubMed ID: 2581074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
